Get The Support That You Need

Having a syndicate of clinical investors can offer a multitude of opportunities.

Watch Video
Get The Support That You Need Image

Clinicians as Investors

Qualified Clinical investors

MedTech Syndicates allows clinicians to pool resources and back your venture. 

The Vetting process

Our vetting process allows you present your innovation under NDA to determine if you are investor ready.

The Pitching Process

We will support the development of your business plan, slide deck and pitch to professional investor level.

A Single Cap Table Entry

Having multiple investors under one vehicle means just one signature is required for the syndicate.

Provision of Additional Services

Clinical investors can collaborate with companies through other roles, for example KOL, Non-executive director, scientific board member etc.

Clinical Trials

Clinical investors can provide input and oversight to support clinical studies.

Arrange an exploratory call with one of our start-up specialists.

Fill in the form and we will send you a Non Disclosure/Non Compete agreement free of charge so that we can begin early stage discussions.

Frequently Asked Questions

How do I apply to MedTech Syndicates?

Applying to MedTech Syndicates is very simple. We just need the name of the company, your name, position in the company and the address of the company.

With this we will then send you over an NDA so that we can have an initial exploratory call to see what MedTech Syndications can do for you.

What are the fees associated with a raise on MedTech Syndicates?

Yes, there are fees associated with raising on MedTech Syndicates.

There is an initial fee. For seed round companies the fee is €2,500 and for Round A companies €1,000 and a % of the raise itself which is taken in shares.

These fees are the cover consultancy for getting your company ready to launch to our clinical investors.

These fees can be recouped in the event of a successful raise.

We also run an incentive program for companies that refer other MedTech companies.

For companies that refer a company that proceeds to work with MedTech Syndicates, MTS discounts the fee by €500.

Terms and conditions do apply but we can discuss this on the exploratory call.

How does MedTech Syndicates deal with NDAs and confidentiality?

Confidentiality is extremely important.

Firstly, we sign a non-disclosure/non-compete with the MedTech company so that we can discuss a potential partnership, review materials and see where additional value can be added.

Secondly, all of our paid up members sign NDAs with us so that they can view sensitive information.

Our goal at MTS is to support and nurture medical innovations and to increase the number of medical innovations getting to market successfully.

How does MTS work?

Once you sign up for the email list we will email you the how to guide to MTS. The basic structure of MTS is as follows:

  • Clinicians join MTS to invest in the MedTech of the future.

  • Companies come to MedTech Syndicates to garner to support of clinicians

  • MTS works with the company to standardise their information for the clinicians to view.

  • MTS launches the company to our members.

  • Members question the founders, management team and decide whether to invest.

  • Companies close out funding and MTS works to complete the Syndicate structure with the company.

  • Syndicates are invest.

How do MedTech Syndicates raise help with “traditional” raises?

A “traditional” raise is one where a company goes to traditional investors such as friends, family, high net worth individuals such as business angels or venture capital and private equity companies.

Some of these actors in investment are very skilled at evaluating companies and others such as family and friends are supporting you.

Professional investors will require a high level of due diligence.

Two areas that investors will want to know about. Firstly, do clinicians support this innovation and secondly, will industry pay for the innovation.

Having a raise on MTS shows traditional investors that there is support from clinicians which helps them come to an investment decision. Thus making investment more probable.

What information is required by MTS to complete a fundraise?

The information that is needed does vary depending on the funding round, stage of the company and the type of product. Here is a basic outline of what you will need:

a) A concise business plan (15-25 pages long)

b) A slide deck 15-20 slides (think a minute/slide)

c) An information deck (similar to a slide deck but with more information)

d) Product introduction video

e) Company introduction video

f) A recorded video pitch

What are the services that are provided by MTS?

a) The services provided to companies will be different depending on the stage of the company and the level of consultancy required.

b) Our main goal is to help to get the items listed in the question above.